myBIO 2013 - Tagged with Personalized Medicine

Allies in Innovation: Biologics and Cell Therapy Manufacturers Think Small for Big Value

2:30 PM - 3:30 PM on Monday, Apr 22, 2013

81 (see all)
Gil Van Bokkelen (see all)

Location Building: S402B
Track Manufacturing of Biologics and Drugs Track

Description: As biologic and cell therapies that open the door to more personalized and targeted medicine gain momentum, the bioprocessing and cell therapy industries are advancing more cost-effective and flexible technologies for...

Big Problems Need Big Solutions - Fixing the Health Care System Using Big Data

3:45 PM - 5:00 PM on Monday, Apr 22, 2013

86 (see all)
Colin Hill (see all)

Location Building: S404BC
Track Personalized Medicine and Diagnostics Forum

Description: Companies like Google have changed the way we live and interact with the world. The biopharma industry started realizing the potential of big data as genomics companies quietly began using it...

Circulating Tumor Cells (CTC): From Enumeration to Comprehensive Molecular Characterization

2:30 PM - 3:30 PM on Monday, Apr 22, 2013

74 (see all)
Howard Scher (see all)

Location Building: S404BC
Track Personalized Medicine and Diagnostics Forum

Description: Inexpensive, minimally-invasive diagnostics tests are important for the effective development of targeted cancer therapies because they can be used repeatedly throughout the course of disease to assess the effect, and even...

Companion Diagnostics: Demonstrating Value and Delivering Success

10:15 AM - 11:30 AM on Tuesday, Apr 23, 2013

131 (see all)
Paul Savuto (see all)

Location Building: S404BC
Track Personalized Medicine and Diagnostics Forum

Description: With a number of new partnership announcements between pharma and diagnostic companies, the companion diagnostics (CDx) field appears ripe to deliver. However, a number of strategic and technical pitfalls still need...

Delivering on the Promise: The Future of Personalized Medicine and Diagnostics

9:30 AM - 10:00 AM on Monday, Apr 22, 2013

169 (see all)
D. Stafford O'Kelly

Location Building: S404BC
Track Personalized Medicine and Diagnostics Forum

Description:

Finding Innovation in Emerging Markets

10:30 AM - 11:30 AM on Wednesday, Apr 24, 2013

120 (see all)
Shaun Grady (see all)

Location Building: N427BC
Track Business Development Track

Description: While biotechnology companies and academic institutions in established markets remain important sources of innovation for pharmaceutical companies looking for licensing deals and partnerships, emerging markets are becoming increasingly attractive. This is...

Finding Your Niche

10:15 AM - 11:30 AM on Monday, Apr 22, 2013

54 (see all)
Kristin Pothier (see all)

Location Building: S401BCD
Track Achieving Regulatory Approval and Compliance Track

Description: Rising regulatory and reimbursement hurdles are putting pressure on biopharma’s commercial engines, and redefining the term "blockbuster." Part of the industry’s response has been to embrace more niche indications, where lower...

How IP Issues Impact Innovations in Biomarker Diagnostics & Personalized Medicine

10:15 AM - 11:30 AM on Monday, Apr 22, 2013

153 (see all)
David Gass (see all)

Location Building: S404BC
Track Personalized Medicine and Diagnostics Forum

Description: Advances in personalized medicine and diagnostic technologies have been made possible by innovators who have done the difficult work to assess and clinically validate which biomarker measurements are relevant to disease...

It’s a Small World After All: Development of Global Pediatric Plans

2:30 PM - 3:30 PM on Wednesday, Apr 24, 2013

Location Building: N426A
Track Achieving Regulatory Approval and Compliance Track

Description: The pediatric provisions within the 2012 FDA Safety and Innovation Act (FDASIA) have a significant impact on the management of pediatric studies both inside and outside the U.S. Now is an...

Lithuanian Biotech - Innovations in Health

9:00 AM - 9:45 AM on Monday, Apr 22, 2013

19 (see all)
Gary Keller (see all)

Location Building: S401BCD
Track International Market Briefings Track

Description: The Lithuanian government is focused on life science innovation as a cornerstone for promoting competitiveness and growth of the country. Key areas include: biotechnology, pharmaceuticals, medical devices, and related fields. The...

Multi-Party and Cross-Border Patent Issues Affecting Biotech Businesses

9:00 AM - 10:15 AM on Tuesday, Apr 23, 2013

75 (see all)
Bernd Allekotte (see all)

Location Building: S404A
Track Biotech Patenting and Tech Transfer Track

Description: Recent developments in U.S. case law may dramatically affect an innovator's ability to protect technologies that competitors may seek to copy and divide among multiple parties and/or in multiple countries. An...

Myriad, Mayo, and Beyond: Developments in the Law of Patentable Subject Matter

10:30 AM - 11:30 AM on Tuesday, Apr 23, 2013

119 (see all)
Mark Fleming (see all)

Location Building: S404A
Track Biotech Patenting and Tech Transfer Track

Description: The question of what products and processes are eligible for patent protection, and in particular the scope of the exception for laws of nature, has been the subject of recent scrutiny...

Orphan and Rare Diseases: Closing Distances in Understanding Larger Disease Mechanisms

10:30 AM - 11:45 AM on Tuesday, Apr 23, 2013

104 (see all)
Robert Beall. PhD (see all)

Location Building: N426C
Track Orphan Disease Forum

Description: Research on rare diseases can shed light on mechanisms and therapeutic opportunities for common diseases. Better tools and improved support models have helped mitigate the special risks of research for rare...

Panacea or Pain: Collaboration in Personalized Medicine

3:45 PM - 5:00 PM on Tuesday, Apr 23, 2013

55 (see all)
Kristin Pothier (see all)

Location Building: S404BC
Track Personalized Medicine and Diagnostics Forum

Description: When it comes to advances in personalized medicine, is collaboration among diagnostic, therapeutics, and life science companies a panacea or the problem? How do companies with competing interests each capture their...

Personalized Medicine and Diagnostics Regulatory Fireside Chat

1:00 PM - 2:15 PM on Monday, Apr 22, 2013

98 (see all)
Amy Miller (see all)

Location Building: S404 BC
Track Personalized Medicine and Diagnostics Forum

Description: This fireside discussion will explore the current landscape of regulatory issues impacting the personalized medicine industry. Panelists will address pre- and post-market topics, from companion diagnostics to the regulation of laboratory-developed...

Personalized Medicine Forum Opening Remarks

9:15 AM - 9:30 AM on Monday, Apr 22, 2013

51 (see all)

Location Building: S404 BC
Track Breakout Sessions

Description:

Policy Changes to Advance Personalized Medicine

2:30 PM - 3:30 PM on Tuesday, Apr 23, 2013

63 (see all)
Pascale Witz (see all)

Location Building: S404BC
Track Personalized Medicine and Diagnostics Forum

Description: This panel will explore policy barriers to the advancement of personalized medicine, and discuss potential solutions to foster innovation and continued progress in this area. Panelists will discuss challenges relating to...

Say It Ain't So, You Can Now IPO

10:30 AM - 11:30 AM on Wednesday, Apr 24, 2013

64 (see all)
Ali Behbahani (see all)

Location Building: N426B
Track Finance Track

Description: Private biotech companies require access to significant capital to develop their pipelines. The IPO market adds a desperately needed source of capital and can increase the intrinsic value of biotechs overall....

The Changing Landscape for Companion Diagnostic Deals

9:00 AM - 10:00 AM on Tuesday, Apr 23, 2013

106 (see all)
James Creeden (see all)

Location Building: S404BC
Track Personalized Medicine and Diagnostics Forum

Description: Both diagnostic and pharmaceutical companies have been struggling to structure research collaborations to develop of companion diagnostics. Current reimbursement policies do not appropriately reward quality and innovation in diagnostic tests. As...

Using NIH Resources to Help Advance Biomedical Technology and Drug Projects to Industry Adoption

9:00 AM - 10:15 AM on Wednesday, Apr 24, 2013

128 (see all)
Rajesh Ranganathan (see all)

Location Building: N427BC
Track Business Development Track

Description: Biotechnology companies and university researchers urgently need additional funding and research resources to move technologies and therapeutic programs to industry adoption (i.e. investor funding and corporate partnerships). During the last year,...

2:30 PM - 3:30 PM on Monday, Apr 22, 2013

3:45 PM - 5:00 PM on Monday, Apr 22, 2013

2:30 PM - 3:30 PM on Monday, Apr 22, 2013

10:15 AM - 11:30 AM on Tuesday, Apr 23, 2013

9:30 AM - 10:00 AM on Monday, Apr 22, 2013

10:30 AM - 11:30 AM on Wednesday, Apr 24, 2013

10:15 AM - 11:30 AM on Monday, Apr 22, 2013

10:15 AM - 11:30 AM on Monday, Apr 22, 2013

2:30 PM - 3:30 PM on Wednesday, Apr 24, 2013

9:00 AM - 9:45 AM on Monday, Apr 22, 2013

9:00 AM - 10:15 AM on Tuesday, Apr 23, 2013

10:30 AM - 11:30 AM on Tuesday, Apr 23, 2013

10:30 AM - 11:45 AM on Tuesday, Apr 23, 2013

3:45 PM - 5:00 PM on Tuesday, Apr 23, 2013

1:00 PM - 2:15 PM on Monday, Apr 22, 2013

9:15 AM - 9:30 AM on Monday, Apr 22, 2013

2:30 PM - 3:30 PM on Tuesday, Apr 23, 2013

10:30 AM - 11:30 AM on Wednesday, Apr 24, 2013

9:00 AM - 10:00 AM on Tuesday, Apr 23, 2013

9:00 AM - 10:15 AM on Wednesday, Apr 24, 2013

Need to make an update?